New data support tailoring regional nodal irradiation in patients treated with neoadjuvant chemotherapy on the basis of their ...

A UK biotech firm spent years gathering genetic data that has uncovered 1 million previously unknown microbial species and ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

Other appointments to BIO's board for the 2025 through 2026 term include: Arcutis Bio's Frank Watanabe, named vice-chair; ...

The VERONA trial evaluated the safety and efficacy of venetoclax with azacitidine in treatment-naïve adults with higher-risk MDS.

In this video, Susana M. Campos, MD, MPH, discusses results from a phase 3 clinical trial of dostarlimab and niraparib in advanced ovarian cancer, presented at ASCO Annual Meeting.The FIRST/ENGOT-OV44 ...

The AI unicorn's Perturb-seq atlas is publicly available and detects dose-dependent genetic effects to enhance predictive power for drug discovery.

A closing session on Day 1 of HPLC on Monday, June 15, 2025, ended with a topic that is on everyone’s lips in separation science: oligonucleotide analysis. The session was chaired by two luminaries in ...

FDA Commissioner Dr Martin Makary took the stage at BIO 2025 to detail the way he and his team have been challenging “deeply ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, and Noetik, a leader in AI-driven spatial and multimodal biology, today announced a research collaboration to develop predictive ...